Trials / Withdrawn

WithdrawnNCT03639129

Improving Characterization of Calcifications With Contrast-Enhanced Mammography

Status: Withdrawn
Phase: N/A
Study type: Interventional
Enrollment: 0 (actual)

Sponsor: Washington University School of Medicine · Academic / Other
Sex: Female
Age: 30 Years
Healthy volunteers: Not accepted

Summary

The purpose of this study protocol is to assess whether contrast-enhanced mammography (CEM) will increase the accuracy of characterization of microcalcifications detected on screening mammography prior to biopsy as either benign, high risk, or malignant.

Conditions

Mammography

Interventions

Type	Name	Description
DEVICE	Contrast-enhanced mammography	Contrast-enhanced mammography was FDA approved in 2012 and is currently being used in both clinical and research settings at breast imaging centers throughout the world
PROCEDURE	Biopsy	Standard of care

Timeline

Start date: 2019-05-31
Primary completion: 2021-05-31
Completion: 2021-05-31
First posted: 2018-08-20
Last updated: 2019-05-14

Regulatory

FDA-regulated device study

Source: ClinicalTrials.gov record NCT03639129. Inclusion in this directory is not an endorsement.